New TGA crackdown targets illegal peptides

The Therapeutic Goods Administration has escalated its enforcement against illegal peptide products, putting the fast-growing grey market for unapproved goods squarely in its sights.

The regulator says the issue is being driven by rising imports and online advertising, and that it will respond with product seizures, infringement notices, import interventions and legal penalties.

The warning is aimed at people selling, promoting or buying peptide products that are not approved therapeutic goods in Australia. The TGA says many of these products have not been assessed for safety, quality or effectiveness.

TGA chief Professor Anthony Lawler said the availability of unapproved peptide products has increased, along with evidence of risk to consumers. He urged Australians to be cautious about buying such products online, especially from overseas websites, marketplaces or social media sellers.

Why the TGA is acting

Peptides have become a visible part of Australia’s online wellness and performance market, often marketed for anti-ageing, fitness, bodybuilding or other enhancement uses.

The regulator’s concern is not limited to the products themselves. It also extends to the way they are advertised, the way they are imported and the way they are sold through online channels that can move faster than traditional regulation.

The TGA says many of the products being offered are unapproved therapeutic goods and are not included on the Australian Register of Therapeutic Goods. That means they have not gone through the standard assessment process for medicines supplied in Australia.

The agency says that creates a consumer-safety problem, particularly where products may be mislabelled, poorly labelled or otherwise outside the regulated medicines system.

Enforcement and border action

The crackdown gives the TGA a broader enforcement focus across the supply chain. Importers, manufacturers, advertisers and sellers all face the possibility of action if they are involved in unlawful supply.

A recent joint operation involving the TGA, Australian Border Force and Victoria Police already seized illegal steroids and peptides with an estimated street value of more than $2 million.

That operation showed how the issue crosses from online marketing into border enforcement and criminal investigations. It also underlines why the regulator is treating peptides as more than a niche health-market problem.

The TGA has previously been weighing whether it needs stronger powers to tackle the grey market for unapproved peptides. This week’s escalation suggests it is prepared to use existing tools aggressively while that broader policy question remains unresolved.

What happens next

The regulator has not yet named specific products, sellers or platforms as priority targets. That leaves open how broad the crackdown will be and whether it will focus first on importers, online advertisers or overseas suppliers.

Further developments to watch include additional seizures, import blocks and possible prosecutions, along with any follow-up from border officials or state police.

There is also a policy question hanging over the crackdown: whether the TGA will seek stronger legal powers to deal with peptide supply and advertising, or continue relying on its current enforcement toolkit.

For now, the regulator’s message is that unapproved peptide products are being treated as a consumer-safety risk, and the people selling them should expect closer scrutiny.